Buprenorphine-Naloxone Cuts Nonfatal Overdose vs XR Naltrexone Post-Withdrawal
Analysis Pain / Palliative Care Confirmatory Grade: Moderate
Hsu HE, Lodi S, Yan S, et al.
Jul 14, 2026 · Published in: JAMA Network Open
Buprenorphine-naloxone reduces overdose risk more effectively than XR naltrexone.
Stepped-Care Smoking Cessation: Meds First, Devices and Harm Reduction Later
Analysis Behavioral Health / Addiction Medicine Confirmatory Grade: Low
Croghan IT, Hurt RT, Elrashidi MY, et al.
Jul 13, 2026 · Published in: Journal of Primary Care & Community Health
Maximize smoking cessation success with new digital and harm-reduction tools.
North Carolina Pharmacists Ambivalent but Willing on Methadone Dispensing
Analysis Pain / Palliative Care Hypothesis-generating Grade: Low
Carpenter DM, Shubel C, Marley GT, et al.
Jul 13, 2026 · Published in: Journal of Addiction Medicine
Pharmacists willing but cautious with methadone services for OUD.
Aspirin Monotherapy Noninferior to Rivaroxaban Bridge After Arthroplasty
Analysis Cardiology / Anticoagulation Practice-changing Grade: High
Shivakumar S, Matino D, Zukor D, et al.
Jul 12, 2026 · Published in: N Engl J Med
Aspirin matches rivaroxaban's efficacy in preventing post-surgical blood clots.
D-Dimer/Fibrinogen Ratio Predicts Poor Post-Thrombolysis Stroke Outcomes
Analysis Neurology / Neuropharmacology Hypothesis-generating Grade: Low
Zhang X, Fu Y, Lu J
Jul 11, 2026 · Published in: Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
New biomarker DFR predicts poor stroke outcomes post-thrombolysis.
Reweighted MRC-ICU 2.0 Improves Complexity-Based Outcome Prediction
Analysis Clinical Pharmacy Practice Hypothesis-generating Grade: Low
Zhao B, Shen Y, Henry K, et al.
Jul 11, 2026 · Published in: Pharmacotherapy
MRC-ICU 2.0 boosts prediction accuracy for ICU outcomes.
JAK Inhibitors Show Limited Efficacy in Refractory JIA Uveitis
Analysis Rheumatology / Immunology Hypothesis-generating Grade: Very Low
Baquet-Walscheid K, Wortmann C, Rothaus K, et al.
Jul 11, 2026 · Published in: Pediatric Rheumatology Online Journal
Janus kinase inhibitors show limited efficacy in JIA-associated uveitis.
Pharmacist anti-MRSA time-outs cut use mainly in emergency departments
Analysis Pharmacokinetics / TDM Confirmatory Grade: Low
Yamamoto R, Tagashira Y, An DD, et al.
Jul 11, 2026 · Published in: Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
Targeted pharmacist-led interventions reduce intensive care antibiotic use.
Capsid Inhibitors and Lenacapavir: A Mechanistic and Resistance Review
Analysis Infectious Disease / Antimicrobials Confirmatory Grade: Low
Mahdi M, Lakatos B, Mótyán JA, et al.
Jul 10, 2026 · Published in: PLOS Pathogens
HIV capsid inhibitors could transform HIV treatment strategies.
Subcutaneous Natalizumab Cuts Chair Time, Cost, Boosts Quality of Life
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Filippi M, Grimaldi LME, Brescia Morra V, et al.
Jul 10, 2026 · Published in: Journal of Neurology
Subcutaneous natalizumab streamlines MS care while enhancing patient experience.
Undiluted IV Push Valproic Acid Shows Favorable Safety Across 5500 Doses
Analysis Neurology / Neuropharmacology Confirmatory Grade: Low
Rollins S, Radosevich JJ, Sammani N, et al.
Jul 10, 2026 · Published in: Journal of Neurology
Undiluted IV push valproic acid proves safe for rapid seizure treatment.
PID versus MPC Algorithm Response to Unannounced Meals in Adolescents
Analysis Endocrinology / Diabetes / Obesity Hypothesis-generating Grade: Low
Lo Presti D, Scirè Calabrisotto S, Tomaselli LG, et al.
Jul 10, 2026 · Published in: Endocrine
The PID algorithm optimizes glycemic control for unannounced meals in adolescents with type 1 diabetes.
International Hypertension Guidelines in CKD: ESH, ESC, KDIGO, and AHA/ACC Compared
Guideline Nephrology / Renal Pharmacy Confirmatory Grade: Moderate
Stambolliu E, Stathopoulou E, Bora M, et al.
Jul 9, 2026 · Published in: Clinical Hypertension
Navigating global hypertension guidelines in CKD can enhance patient care.
EHR care-complexity score tracks CLABSI risk in ICU adults
Analysis Clinical Pharmacy Practice Hypothesis-generating Grade: Low
Li N, Huang J, Liu J, et al.
Jul 9, 2026 · Published in: Frontiers in Public Health
Higher care-exposure burden increases CLABSI risk in critical care.
Transporters and CYP3A4 Shape Daraxonrasib Brain and Plasma Exposure
Analysis Oncology Pharmacy Hypothesis-generating Grade: Low
Arguedas D, Bui V, Law T, et al.
Jul 8, 2026 · Published in: Pharmacological Research
Transporter interactions may challenge daraxonrasib's effectiveness against brain metastases.